MARKET

CPIX

CPIX

Cumberland
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.960
-0.030
-1.00%
Closed 16:00 11/23 EST
OPEN
2.990
PREV CLOSE
2.990
HIGH
3.019
LOW
2.930
VOLUME
2
TURNOVER
--
52 WEEK HIGH
5.52
52 WEEK LOW
2.770
MARKET CAP
44.51M
P/E (TTM)
-7.8307
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Cumberland Pharmaceuticals Announces RediTrex, New Methotrexate Delivery System
Introducing RediTrex®, A New Methotrexate Delivery System NASHVILLE, Tenn., Nov. 17, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a U.S. specialty pharmaceutical company,
Benzinga · 6d ago
Introducing RediTrex®, A New Methotrexate Delivery System
PR Newswire · 6d ago
Cumberland Pharmaceuticals (CPIX) Q3 Earnings and Revenues Surpass Estimates
Cumberland (CPIX) delivered earnings and revenue surprises of 128.57% and 7.45%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 11/10 22:45
Recap: Cumberland Q3 Earnings
Shares of Cumberland (NASDAQ:CPIX) were flat after the company reported Q3 results.Quarterly Results Earnings per share increased 100.00% over the past year to $0.02, which beat the estimate of ($0.07).Revenue of $9,251,000 decreased by 10.81% year over year, which beat the estimate of $8,610,000.Guidance Cumberland hasn't issued any earnings guidance for the time being.Revenue guidance hasn't been issued by the company for now.Details Of The Call Date: Nov 10, 2020View more earnings on CPIXTime: 04:30 PMET Webcast URL: https://www.intrado.com/en/digital-media/investor-relationsRecent Stock Performance 52-week high: $5.8052-week low: $2.77Price action over last quarter: down 12.36%Company Description Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It focuses on the acquisition, development, and commercialization of branded prescription products. The company provides prescription products to hospital acute care and gastroenterology to address unmet or poorly met medical needs. Its product brands include Acetadote, Caldolor, Kristalose, Omeclamox- Pak, Vaprisol and Ethyol.See more from Benzinga * Click here for options trades from Benzinga * Earnings Scheduled For November 10, 2020 * Cumberland's Earnings: A Preview(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga · 11/10 22:21
Cumberland Pharmaceuticals EPS beats by $0.10, beats on revenue
Cumberland Pharmaceuticals (CPIX): Q3 GAAP EPS of -$0.08 beats by $0.10.Revenue of $9.25M (+32.1% Y/Y) beats by $0.64M.Press Release
Seekingalpha · 11/10 21:15
Cumberland Pharmaceuticals, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / November 10, 2020 / Cumberland Pharmaceuticals, Inc.
ACCESSWIRE · 11/10 19:30
Newly Published Literature Supports Use Of Caldolor® For Postoperative Pain And Reduction Of Opioid Use
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced the results of a new review of clinical studies evaluating Caldolor® (ibuprofen) Injection, which was published in the journal Clinical Therapeutics. The manuscript continues an updated integrated safety
PR Newswire · 08/18 13:35
Cumberland Pharma CEO Sends Shareholder, Employee, Partner Letter Following Q2 Results Tues. Evening
https://investor.cumberlandpharma.com/static-files/1ea1ca5d-acd5-4890-993d-a975510fbd91
Benzinga · 08/12 14:44
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CPIX. Analyze the recent business situations of Cumberland through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CPIX stock price target is 8.50 with a high estimate of 8.50 and a low estimate of 8.50.
EPS
Institutional Holdings
Institutions: 39
Institutional Holdings: 4.05M
% Owned: 26.94%
Shares Outstanding: 15.04M
TypeInstitutionsShares
Increased
7
11.97K
New
5
-224
Decreased
6
123.85K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.85%
Pharmaceuticals & Medical Research
-0.35%
Key Executives
Chairman/Chief Executive Officer/Director
A. Kazimi
Chief Financial Officer
Michael Bonner
Executive Vice President/Director
Martin Cearnal
Executive Vice President
Leo Pavliv
Chief Compliance Officer/Vice President
James Herman
Independent Director
Gordon Bernard
Independent Director
Joseph Galante
Independent Director
Jonathan Griggs
Independent Director
Joey Jacobs
Independent Director
James Jones
Independent Director
Kenneth Krogulski
Independent Director
Caroline Young
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CPIX
Cumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Vaprisol (conivaptan) Injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Hepatoren (ifetroban) Injection, and Boxaban (ifetroban) oral capsules for the treatment of patients with aspirin-exacerbated respiratory disease (AERD).
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Cumberland Pharmaceuticals, Inc. stock information, including NASDAQ:CPIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPIX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CPIX stock methods without spending real money on the virtual paper trading platform.